(To read about Jon's mega-collection, The Matrix Revealed, click here.)
|
Detecting cancer: can you trust all the tests?
By Jon Rappoport
I'm not talking about all tests for cancer. I've only looked into two. This is what I've discovered.
There is a blood test, which looks for a bio-marker labeled
CA125. There are doctors who will tell you that a highly positive result
indicates a high probability of cancer.
Imagine being a patient on the receiving end of that news.
But wait. If you go to other sources---and no, I'm not
talking about alternative practitioners, I'm talking about the
mainstream---you'll get a distinctly different view.
How about a quite prestigious organization---the Mayo Clinic?
https://www.mayoclinic.org/tests-procedures/ca-125-test/about/pac-20393295
"A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood."
"A CA 125 test may be used to monitor certain cancers during
and after treatment. In some cases, a CA 125 test may be used to look
for early signs of ovarian cancer in people with a very high risk of the
disease."
"A CA 125 test isn't accurate enough to use for ovarian
cancer screening in general because many noncancerous conditions can
increase the CA 125 level."
"Many different conditions can cause an increase in CA 125,
including normal conditions, such as menstruation, and noncancerous
conditions, such as uterine fibroids. Certain cancers may also cause an
increased level of CA 125, including ovarian, endometrial, peritoneal
and fallopian tube cancers."
"Your doctor may recommend a CA 125 test for several reasons:
But such monitoring hasn't been shown to improve the outcome for those
with ovarian cancer, and it might lead to additional and unnecessary
rounds of chemotherapy or other treatments."
"...some people with ovarian cancer may not have an increased
CA 125 level. And no evidence shows that screening with CA 125
decreases the chance of dying of ovarian cancer. An elevated level of CA
125 could prompt your doctor to put you through unnecessary and
possibly harmful tests."
"A number of normal and noncancerous conditions can cause an elevated CA 125 level, including:
"None of the major professional organizations recommend using
the CA125 as a screening test for those with an average risk of ovarian
cancer."
Is that clear enough? I hope so.
Let's move on to another test for cancer. It's a version of a PET scan.
From avrin.org: "A PET scan uses a small amount
of a radioactive drug, or tracer, to show differences between healthy
tissue and diseased tissue. The most commonly used tracer is called FDG
(fluorodeoxyglucose), so the test is sometimes called an FDG-PET scan.
Before the PET scan, a small amount of FDG is injected into the
patient..."
The theory goes this way: cancer cells have an affinity for
FDG and "grab on to" it. Thus, these cancer cells "light up" on the PET
scan and can easily be seen. Tumors and metastases can be observed.
Yes, but...
https://www.oncolink.org/cancer-treatment/procedures-diagnostic-tests/nuclear-medicine-tests/introduction-to-pet-ct-imaging
"Cancer cells are not always the only 'PET avid cells' (or
cells that take up the FDG) in the body. It is important to remember
that a PET scan is not able to distinguish metabolic activity due to
tumor from activity due to non cancerous processes, such as inflammation
or infection."
https://link.springer.com/article/10.1007/s10151-015-1308-3
"In cancer cells, there is an overproduction of glucose
transporters and, as a result, increased FDG uptake. However, not all
PET-positive lesions are cancer, and in many instances, PET findings can
be false positive. ... Inflammatory cells also have increased metabolic
rates and, as a result, are FDG avid."
https://link.springer.com/article/10.1007/s10151-015-1308-3
"Many of us have had patients or know of patients who were
treated by the medical oncologist for stage IV cancer only to find out
what was assumed to be a metastatic lesion was benign on pathology.
Other patients have undergone multiple biopsies of supposed metastatic
mesenteric lymph nodes that subsequently turned out to be fat necrosis
or a granulomatous reaction. FDG-positive lesions often mean cancer, but
not always. A variety of lesions have increased FDG radiotracer [the
"lighting up" phenomenon] including infection, inflammation, autoimmune
processes, sarcoidosis, and benign tumors. If such conditions are not
identified accurately and in a timely manner, misdiagnosis can lead to
inadequate therapies."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259390/
"Glucose however acts as a basic energy substrate for many
tissues, and so 18F-FDG activity can be seen both physiologically and in
benign conditions. In addition, not all tumors take up FDG [3-5].
The challenge for the interpreting physician is to recognize these
entities and avoid the many pitfalls associated with 18F-FDG PET-CT
imaging."
The question is, after a patient is told he has received a
positive PET scan, indicating cancer, will the physician spell out all
the factors that could have made the test read FALSELY POSITIVE? Will an
intelligent and honest and informed conversation take place, or will
the doctor shove the test results at the patient and declare: "You have
cancer."
And if that cancer diagnosis is given, will the patient be in
a position to voice questions through prior knowledge, and undertake a
reasonable dialogue with his doctor?
How do doctors normally hand down test findings? In a
balanced way, or from on high, with all the presumed authority of
unchallengeable experts?
Are there doctors who don't even know these two diagnostic
tests are rife with falsely positive readings? Yes, there are. And if
they deliver papal edicts based on their ignorance, they can cause great
harm.
|
|
Use this link to order Jon's Matrix Collections.
|
|
Jon Rappoport
The
author of three explosive collections, THE MATRIX REVEALED, EXIT FROM
THE MATRIX, and POWER OUTSIDE THE MATRIX, Jon was a candidate for a US
Congressional seat in the 29th District of California. He maintains a
consulting practice for private clients, the purpose of which is the
expansion of personal creative power. Nominated for a Pulitzer Prize, he
has worked as an investigative reporter for 30 years, writing articles
on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin
Magazine, Stern, and other newspapers and magazines in the US and
Europe. Jon has delivered lectures and seminars on global politics,
health, logic, and creative power to audiences around the world.
|
|
You can find this article and more at NoMoreFakeNews.com.
|
No comments:
Post a Comment